Selle Therapeutics Rises 17.49% Amid Uptrend in Dental Treatment (Implants, etc.) Theme

On the 21st, the dental treatment (including implants) theme rose by 3.13% compared to the previous day, showing strength, while Cellma Therapeutics, a related stock attracting attention, surged by 17.49% compared to the previous day. Cellma Therapeutics is known as a distributor of gift certificate discounts and dental materials.

[Graph] Major stock price changes in the dental treatment (including implants) theme

According to provisional data compiled at 10:16, foreigners are net selling -4,000 shares of Cellma Therapeutics.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Cellma Therapeutics' quant financial score is 0.2 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to dental treatment (including implants). This can be interpreted as Cellma Therapeutics having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Vatech ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.